01 . 03 .2019
Press release
Galderma: New data reveals benefits of combining oral and topical treatment in patients with severe papulopustular rosacea
01 . 03 .2019
Press release
Galderma Announces Publication of Pivotal Phase 3 PERFECT 1 and PERFECT 2 Clinical Trials of Trifarotene in Patients with Moderate Facial and Truncal Acne in the Journal of the American Academy of Dermatology
23 . 01 .2019
Press release
Galderma Announces Formation of Women in Aesthetics Leadership Council
13 . 12 .2018
Press release
Galderma Announces New Collaborations with Top Aesthetic Professional Skincare Brands
15 . 11 .2018
Press release
International Dermatology Community Voting for the 2018 Galderma SKINPACT Awards
05 . 11 .2018
Press release
Galderma Announces FDA Approval of Restylane® Lyft For Midface Injection via Cannula
05 . 11 .2018
Press release
Galderma Partners with National Breast Cancer Foundation for 4th Annual Pink Day Event to Increase Breast Cancer Awareness
31 . 10 .2018
Press release
Galderma Announces Positive Results from Phase 2b Study of Nemolizumab in Patients with Moderate-to-Severe Atopic Dermatitis
25 . 10 .2018
Press release
Galderma Announces ASPIRE Rewards Program Reaches One Million Members